Wild Bird Surveillance

In 2006, the National Avian Influenza Wild Bird (NAIWB) Steering Group was established to ensure national coordination and collaboration of wild bird avian influenza surveillance activities.

WHA provides support to the NAIWB Steering Group and collates avian influenza (AI) surveillance data from wild birds sampled across Australia. The NAIWB Steering Group meets quarterly via teleconference with one annual face to face meeting. In 2017, surveillance activities included testing for Avian Paramyxoviruses (APMVs), predominantly targeting the APMV-1.

The NAIWB Surveillance Program activities are conducted Australia-wide, with funding provided by the Australian Government Department of Agriculture, Fisheries and Forestry and in 2011/12 funding from the Rural Industries Research and Development Corporation (RIRDC) Chicken Meat Program. Significant in-kind support is provided by the jurisdictional agencies, researchers and representative’s institutions.

The NAIWB Surveillance Program has two main components: targeted surveillance and general surveillance. Targeted surveillance, for AI, will continue to focus on sampling from Anseriformes (waterfowl), specifically from locations where there is known mixing with birds from the Charadriiformes (shorebirds) Order and that bring waterfowl into close proximity to poultry and humans. Where possible, surveillance will continue in locations previously sampled to obtain longitudinal data. General surveillance focuses on exclusion of AIV and APMVs from mass mortality and morbidity events in wild birds around Australia and the Australian Antarctic Territory. 

Between July 2005 and December 2022, over 135,000 wild birds have been tested for influenza viruses. To date, no high pathogenicity (Avian Influenza Virus) AIVs nor virulent strains of APMV-1 have been identified in Australian wild birds. However, targeted surveillance activities continue to result in evidence of a wide range of subtypes of AI viruses of low pathogenicity. Almost all AIV subtypes have been detected, including low pathogenicity avian influenza (LPAI) H5 and H7 subtypes, in wild birds in Australia. 

Surveillance Menu
echidna standing up tall looking looking at camera and standing on brown dirt

> WHA Coordinators & Environment Representatives

> Sentinel Surveillance

> Wild Bird Surveillance

> Bat Health Focus Group

> National Significant Disease Investigation Program

> eWHIS - Wildlife Health Information System

photo of brown booby flying through the sky with wings stretched with the blue sky background
OBJECTIVES OF THE NAIWB SURVEILLANCE PROGRAM
  1. To regularly detect AIVs by sampling wild birds, in order to:

    • Contribute to a better understanding of AIV genetic variation and gene flow of subtypes, ecology and epidemiology to support industry and human and wildlife health strategic risk assessment and management, and
    • Generate AIVs sequence data required to monitor genetic diversity and variation of AIVs circulating in Australia and maintain a contemporary Australian AIV sequence “library”, and,
    • Maintain fit-for-purpose diagnostic tests and national laboratory diagnostic capacity and capability.

  2. To share and communicate data nationally, and internationally,

  3. To contribute to One Health through regular communication of AIV data to the Department of Health with specific analysis of wild bird AIVs for likelihood of infection and transmission in humans, and

  4. To exclude AIVs, specifically H5 and H7, via investigation of significant, unexplained or mass mortality events in wild birds.
Support WHA

Wildlife Health Australia (WHA) leads national action to respond to emerging health issues affecting Australia’s wildlife. Today, you can join us, donate to our conservation projects or follow us to protect our unique and precious wildlife.

SUPPORT WHA
koala snuggled with its baby in tree
Join the Community!

Wildlife Health Australia aims to link, inform and support people and organisations who work with or have an interest in wildlife health across Australia through technical advice, facilitation, communications and professional support.

 

1. To regularly detect AIVs by sampling wild birds, in order to:

  • Contribute to a better understanding of AIV genetic variation and gene flow of subtypes, ecology and epidemiology to support industry and human and wildlife health strategic risk assessment and management, and
  • Generate AIVs sequence data required to monitor genetic diversity and variation of AIVs circulating in Australia and maintain a contemporary Australian AIV sequence “library”, and,
  • Maintain fit-for-purpose diagnostic tests and national laboratory diagnostic capacity and capability.

2. To share and communicate data nationally, and internationally,

3. To contribute to One Health through regular communication of AIV data to the Department of Health with specific analysis of wild bird AIVs for likelihood of infection and transmission in humans, and

4. To exclude AIVs, specifically H5 and H7, via investigation of significant, unexplained or mass mortality events in wild birds.

1. To regularly detect AIVs by sampling wild birds, in order to:

    • Contribute to a better understanding of AIV genetic variation and gene flow of subtypes, ecology and epidemiology to support industry and human and wildlife health strategic risk assessment and management, and

    • Generate AIVs sequence data required to monitor genetic diversity and variation of AIVs circulating in Australia and maintain a contemporary Australian AIV sequence “library”, and,

    • Maintain fit-for-purpose diagnostic tests and national laboratory diagnostic capacity and capability.

2. To share and communicate data nationally, and internationally,

3. To contribute to One Health through regular communication of AIV data to the Department of Health with specific analysis of wild bird AIVs for likelihood of infection and transmission in humans, and

4. To exclude AIVs, specifically H5 and H7, via investigation of significant, unexplained or mass mortality events in wild birds.